WallStreetZenWallStreetZen

NASDAQ: RPTX
Repare Therapeutics Inc Stock

$3.53+0.01 (+0.28%)
Updated Jun 21, 2024
RPTX Price
$3.53
Fair Value Price
N/A
Market Cap
$149.83M
52 Week Low
$2.98
52 Week High
$13.85
P/E
-3.24x
P/B
0.65x
P/S
2.03x
PEG
N/A
Dividend Yield
N/A
Revenue
$97.86M
Earnings
-$45.69M
Gross Margin
100%
Operating Margin
-59.33%
Profit Margin
-46.7%
Debt to Equity
0.13
Operating Cash Flow
-$83M
Beta
1.34
Next Earnings
Aug 7, 2024
Ex-Dividend
N/A
Next Dividend
N/A

RPTX Overview

Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that focuses on genomic instability, including DNA damage repair. Its lead product candidate is RP-3500, an oral small molecule inhibitor for the treatment of solid tumors with specific DNA damage repair-related genomic alterations. It is also developing RP-6306, which is under Phase I clinical trial for tumors with genetic alterations characterized by CCNE1 amplification; and Polymerase Theta program, a SL target associated with BRCA mutations and other genomic alterations. The company was incorporated in 2016 and is headquartered in Montreal, Canada.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how RPTX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

RPTX is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
RPTX is good value based on its book value relative to its share price (0.65x), compared to the US Biotechnology industry average (6.2x)
P/B vs Industry Valuation
RPTX is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more RPTX due diligence checks available for Premium users.

Be the first to know about important RPTX news, forecast changes, insider trades & much more!

RPTX News

Valuation

RPTX price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-3.24x
Industry
-5.75x
Market
30.75x

RPTX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.65x
Industry
6.2x
RPTX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

RPTX's financial health

Profit margin

Revenue
$52.4M
Net Income
$13.2M
Profit Margin
25.1%
RPTX's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
RPTX's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$263.1M
Liabilities
$31.1M
Debt to equity
0.13
RPTX's short-term assets ($254.67M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
RPTX's short-term assets ($254.67M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
RPTX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$11.9M
Investing
-$20.3M
Financing
$375.0k
RPTX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

RPTX vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
RPTX$149.83M+0.28%-3.24x0.65x
CAPR$149.51M-1.26%-5.66x8.11x
DRTS$150.49M-4.42%-5.14x1.78x
SYRS$149.14M+5.08%-1.10x9.91x
ZURA$149.09M-1.16%-2.48x2.44x

Repare Therapeutics Stock FAQ

What is Repare Therapeutics's quote symbol?

(NASDAQ: RPTX) Repare Therapeutics trades on the NASDAQ under the ticker symbol RPTX. Repare Therapeutics stock quotes can also be displayed as NASDAQ: RPTX.

If you're new to stock investing, here's how to buy Repare Therapeutics stock.

What is the 52 week high and low for Repare Therapeutics (NASDAQ: RPTX)?

(NASDAQ: RPTX) Repare Therapeutics's 52-week high was $13.85, and its 52-week low was $2.98. It is currently -74.51% from its 52-week high and 18.46% from its 52-week low.

How much is Repare Therapeutics stock worth today?

(NASDAQ: RPTX) Repare Therapeutics currently has 42,445,406 outstanding shares. With Repare Therapeutics stock trading at $3.53 per share, the total value of Repare Therapeutics stock (market capitalization) is $149.83M.

Repare Therapeutics stock was originally listed at a price of $30.80 in Jun 19, 2020. If you had invested in Repare Therapeutics stock at $30.80, your return over the last 4 years would have been -88.54%, for an annualized return of -41.82% (not including any dividends or dividend reinvestments).

How much is Repare Therapeutics's stock price per share?

(NASDAQ: RPTX) Repare Therapeutics stock price per share is $3.53 today (as of Jun 21, 2024).

What is Repare Therapeutics's Market Cap?

(NASDAQ: RPTX) Repare Therapeutics's market cap is $149.83M, as of Jun 23, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Repare Therapeutics's market cap is calculated by multiplying RPTX's current stock price of $3.53 by RPTX's total outstanding shares of 42,445,406.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.